Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- Check6 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedMinor platform update: Revision: v3.4.2 added and Revision: v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedMinor site revision updating from v3.4.0 to v3.4.1 with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedThe update adds a glossary toggle and updates UI/metadata labels, including capitalization changes for QC criteria text and the No FEAR Act Data label, and upgrades the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page header, indicating a minor maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe Study Details page reorganizes location data by removing the state-specific 'Florida Locations', 'Michigan Locations', and 'Texas Locations' subsections and introducing a general 'Locations' section. This update (revision v3.3.3) changes how locations are presented to users.SummaryDifference0.3%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.